Author

Shivani Mittra

Observed names: S Mittra, S. Mittra

Observed institutions: Panacea Biotec (India), Biocon (India), Panjab University, Punjabi University, University of Hong Kong

ORCID: 0000-0002-5488-7140

Observed ORCID: 0000-0002-5488-7140

OpenAlex ID: A5038547140

Intermittent claudication: An overview

2005 · Ashwinkumar V. Meru, Shivani Mittra, et al. · Atherosclerosis · 137

From a glucocentric to a lipocentric approach towards metabolic syndrome

2008 · Shivani Mittra, Vinay S. Bansal, et al. · Drug Discovery Today · 51

Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta

1998 · Shivani Mittra, Manjeet Singh · Molecular and Cellular Biochemistry · 40

Nature of action of sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals

2010 · JosephA Davis, Shuchita Singh, et al. · Indian Journal of Pharmacology · 36

PDF

5-Hydroxytryptamine-inhibiting property of Feverfew: role of parthenolide content.

2000 · S Mittra, A Datta, et al. · PubMed · 36

Increase in weight induced by muraglitazar, a dual PPARα/γ agonist, in db/db mice: adipogenesis/or oedema?

2007 · S Mittra, G Sangle, et al. · British Journal of Pharmacology · 35

PDF

Antihyperglycemic effect of Annona squamosa hexane extract in type 2 diabetes animal model: PTP1B inhibition, a possible mechanism of action?

2012 · Joseph Alex Davis, Suchitra Sharma, et al. · Indian Journal of Pharmacology · 33

PDF

Role of cyclooxygenase in ventricular effects of adrenomedullin: is adrenomedullin a double-edged sword in sepsis?

2004 · Shivani Mittra, Jean-Marc Hyvelin, et al. · American Journal of Physiology-Heart and Circulatory Physiology · 29

Gs and Gi coupling of adrenomedullin in adult rat ventricular myocytes

2005 · Shivani Mittra, Jean-Pierre Bourreau · American Journal of Physiology-Heart and Circulatory Physiology · 26

Role of peripheral 5-HT1A receptors in detrusor over activity associated with partial bladder outlet obstruction in female rats

2007 · Shivani Mittra, Shivani Malhotra, et al. · European Journal of Pharmacology · 20

2022 · Shashank R Joshi, Shivani Mittra, et al. · Expert Opinion on Biological Therapy · 19

Combination of dipeptidylpeptidase IV inhibitor and low dose thiazolidinedione: Preclinical efficacy and safety in db/db mice

2007 · Subhasis Roy, Vivek Khanna, et al. · Life Sciences · 18

Topiramate and Type 2 diabetes: an old wine in a new bottle

2007 · Vivek Khanna, Surendar Arumugam, et al. · Expert Opinion on Therapeutic Targets · 17

Comparative clinical efficacy and safety of insulin glargine 300 U/ml (Toujeo) versus insulin glargine 100 U/ml in type 2 diabetes and type 1 diabetes: A systematic literature review and meta‐analysis

2023 · Shashank R. Joshi, Gursharan Singh, et al. · Diabetes Obesity and Metabolism · 12

Increasing adoption of quality-assured biosimilars to address access challenges in low- and middle-income countries

2024 · Pritha Paul, Rahul Kapur, et al. · Generics and Biosimilars Initiative Journal · 6

Ethnic sensitivity assessments in biosimilar monoclonal antibodies clinical development programmes: necessary or not?

2023 · Sandeep N Athalye, Dev B Baruah, et al. · Generics and Biosimilars Initiative Journal · 6

Comparison of the efficacy and safety of rapid-acting insulin analogs, lispro versus aspart, in the treatment of diabetes: a systematic review of randomized controlled trials

2024 · Rahul Kapur, Shivani Mittra, et al. · Expert Opinion on Biological Therapy · 3

PDF

2023 · Sandeep N Athalye, Shivani Mittra, et al. · Generics and Biosimilars Initiative Journal · 3

Biological evaluation of RBx-0128, a potent and selective dipeptidyl peptidase-IV inhibitor in type 2 diabetes genetic model

2012 · Joseph A. Davis, Pucha S. Kumar, et al. · Indian Journal of Pharmacology · 2

PDF

Aligning environmental, social, and governance to clinical development: moving towards more sustainable clinical trials

2024 · Sandeep Athalye, Shylashree Baraskar, et al. · Generics and Biosimilars Initiative Journal · 1

IDF21-0380 An integrated diabetes ecosystem to address patient barriers in low-income communities in Philippines

2022 · R. Praveen, S. Mittra, et al. · Diabetes Research and Clinical Practice · 1

Author response for "Comparative clinical efficacy and safety of insulin glargine 300 U/ mL (Toujeo) versus insulin glargine 100 U/ mL in Type 2 and Type 1 diabetes mellitus: A systematic literature review and meta‐analysis"

2023 · Shashank R. Joshi, Gursharan Singh, et al. · Publons reviews and discussion

2022 · Shashank R. Joshi, Gursharan Singh, et al. · Publons reviews and discussion

A Phase I, randomized, double-blind, three-group study in healthy participants to evaluate if there is similarity between the amount of study drug in the bloodstream after dosing, the safety of the study drug, any side effects that might be associated with it and laboratory tests of participants’ blood after receiving either Bmab 1200, US Stelara or EU Stelara and to evaluate how the immune system may interact with these drugs

2022 · Shivani Mittra, Shivani Mittra, et al. · http://isrctn.com/

AACE2021-A-1095: An Integrated Diabetes Ecosystem to Address Patient Barriers in Low-Income Communities in Philippines

2021 · Praveen R, Shivani Mittra, et al. · Endocrine Practice

Works count: 31

Citation count: 531

H-index: 13

I10-index: 14